C Difficile

8500 bookmarks
Custom sorting
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease - PubMed
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease - PubMed
Our group has provided specific statements and recommendations, based on best available evidence, with the end goal of providing guidance and general criteria required to promote FMT as a recognised strategy for the treatment of IBD.
·pubmed.ncbi.nlm.nih.gov·
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease - PubMed
Single-spore germination analyses reveal that calcium released during Clostridioides difficile germination functions in a feedforward loop - PubMed
Single-spore germination analyses reveal that calcium released during Clostridioides difficile germination functions in a feedforward loop - PubMed
Clostridioides difficile infections begin when its metabolically dormant spores germinate in response to sensing bile acid germinants alongside amino acid and divalent cation co-germinants in the small intestine. While bile acid germinants are essential for C. difficile spore germinati …
·pubmed.ncbi.nlm.nih.gov·
Single-spore germination analyses reveal that calcium released during Clostridioides difficile germination functions in a feedforward loop - PubMed
Clostridium Diagnostics Market is anticipated to reach US$ 7.8 Billion by 2032, at a CAGR of 12.2%
Clostridium Diagnostics Market is anticipated to reach US$ 7.8 Billion by 2032, at a CAGR of 12.2%
The global Clostridium Diagnostics Market revenue is projected to secure US$ 7.8 Billion by 2032 while recording a CAGR of 12.2% during the forecast period. The growth of the market can be attributed to the growing prevalence of clostridium-related diseases and the growing awareness campaigns lau...
·news.google.com·
Clostridium Diagnostics Market is anticipated to reach US$ 7.8 Billion by 2032, at a CAGR of 12.2%
Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease - PubMed
Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease - PubMed
In this cohort of patients with inflammatory bowel disease and C. difficile infection, 60.6% responded to treatment with fidaxomicin. Of those who did not respond, fecal microbiota transplantation was an effective therapy.
·pubmed.ncbi.nlm.nih.gov·
Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease - PubMed
Antibiotics Associated With Clostridium difficile Infection - PubMed
Antibiotics Associated With Clostridium difficile Infection - PubMed
Introduction Clostridium difficile (C. difficile) is one of the major causes of diarrhea transmitted by the fecal-oral route. C. difficile type BI/NAP1/027 is responsible for the most severe C. difficile infection (CDI). It is a major cause of antibiotic-associated diarrh …
·pubmed.ncbi.nlm.nih.gov·
Antibiotics Associated With Clostridium difficile Infection - PubMed
Evaluating a pilot, structured, face-to-face, antimicrobial stewardship, prospective audit-and-feedback program in emergency general surgery service in a community hospital - PubMed
Evaluating a pilot, structured, face-to-face, antimicrobial stewardship, prospective audit-and-feedback program in emergency general surgery service in a community hospital - PubMed
Structured PAF showed clinical outcomes similar to ad hoc PAF. Structured PAF was well received and was perceived as beneficial by surgical staff.
·pubmed.ncbi.nlm.nih.gov·
Evaluating a pilot, structured, face-to-face, antimicrobial stewardship, prospective audit-and-feedback program in emergency general surgery service in a community hospital - PubMed
Integrating Infection Control and Environmental Management Work Systems to Prevent Clostridioides difficile Infection - PubMed
Integrating Infection Control and Environmental Management Work Systems to Prevent Clostridioides difficile Infection - PubMed
Effective infection prevention and control within healthcare settings requires collaboration and coordination between infection control and environmental management teams. However, the work systems of these teams can be difficult to integrate despite their shared goals. We provide results from a qua …
·pubmed.ncbi.nlm.nih.gov·
Integrating Infection Control and Environmental Management Work Systems to Prevent Clostridioides difficile Infection - PubMed
O-Acetylhomoserine Sulfhydrylase from Clostridioides difficile: Role of Tyrosine Residues in the Active Site - PubMed
O-Acetylhomoserine Sulfhydrylase from Clostridioides difficile: Role of Tyrosine Residues in the Active Site - PubMed
O-acetylhomoserine sulfhydrylase is one of the key enzymes in biosynthesis of methionine in Clostridioides difficile. The mechanism of γ-substitution reaction of O-acetyl-L-homoserine catalyzed by this enzyme is the least studied among the pyridoxal-5'-phosphate-dependent enzymes involved in metabol …
·pubmed.ncbi.nlm.nih.gov·
O-Acetylhomoserine Sulfhydrylase from Clostridioides difficile: Role of Tyrosine Residues in the Active Site - PubMed
The impact of autocancellation of uncollected Clostridioides difficile specimens after 24 hours on reported healthcare-associated infections: A quality improvement intervention - PubMed
The impact of autocancellation of uncollected Clostridioides difficile specimens after 24 hours on reported healthcare-associated infections: A quality improvement intervention - PubMed
The 24-hour autocancellation of uncollected C. difficile orders reduced testing but did not result in reported HAI reduction.
·pubmed.ncbi.nlm.nih.gov·
The impact of autocancellation of uncollected Clostridioides difficile specimens after 24 hours on reported healthcare-associated infections: A quality improvement intervention - PubMed
The microbial derived bile acid lithocholate and its epimers inhibit Clostridioides difficile growth and pathogenicity while sparing members of the gut microbiota - PubMed
The microbial derived bile acid lithocholate and its epimers inhibit Clostridioides difficile growth and pathogenicity while sparing members of the gut microbiota - PubMed
In the search for a novel therapeutic that targets C. difficile , bile acids have become a viable solution. Epimers of bile acids are particularly attractive as they may provide protection against C. difficile while leaving the indigenous gut microbiota largely unaltered. This study sh …
·pubmed.ncbi.nlm.nih.gov·
The microbial derived bile acid lithocholate and its epimers inhibit Clostridioides difficile growth and pathogenicity while sparing members of the gut microbiota - PubMed
Late poor outcomes of Clostridioides difficile infections in oncological patients: A multicentre cohort study - PubMed
Late poor outcomes of Clostridioides difficile infections in oncological patients: A multicentre cohort study - PubMed
Oncological patients presented a higher risk of poor outcomes after CDI. Their early and late mortality rates were higher than in the general population, and in parallel, those undergoing chemotherapy (especially those receiving metronidazole) had higher rates of recurrence.
·pubmed.ncbi.nlm.nih.gov·
Late poor outcomes of Clostridioides difficile infections in oncological patients: A multicentre cohort study - PubMed
Treatment issues in recurrent Clostridioides difficile infections and the possible role of germinants - PubMed
Treatment issues in recurrent Clostridioides difficile infections and the possible role of germinants - PubMed
Clostridioides difficile is the number one cause of hospital-acquired infections in the United States and one of the CDC's urgent-level pathogen threats. The inflammation caused by pathogenic C. difficile results in diarrhea and pseudomembranous colitis. Patients who undergo clinically …
·pubmed.ncbi.nlm.nih.gov·
Treatment issues in recurrent Clostridioides difficile infections and the possible role of germinants - PubMed
Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials - PubMed
Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials - PubMed
Across five clinical trials, RBL was well tolerated in adults with rCDI. In aggregate, these data consistently demonstrated the safety of RBL.
·pubmed.ncbi.nlm.nih.gov·
Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials - PubMed
Patterns of dental antibiotic prescribing in 2017: Australia, England, United States, and British Columbia (Canada) | Infection Control & Hospital Epidemiology | Cambridge Core
Patterns of dental antibiotic prescribing in 2017: Australia, England, United States, and British Columbia (Canada) | Infection Control & Hospital Epidemiology | Cambridge Core
Patterns of dental antibiotic prescribing in 2017: Australia, England, United States, and British Columbia (Canada) - Volume 43 Issue 2
·cambridge.org·
Patterns of dental antibiotic prescribing in 2017: Australia, England, United States, and British Columbia (Canada) | Infection Control & Hospital Epidemiology | Cambridge Core
Association of Depression With Incident Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis | Inflammatory Bowel Diseases | Oxford Academic
Association of Depression With Incident Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis | Inflammatory Bowel Diseases | Oxford Academic
AbstractBackground. Individuals with a history of depression/depressive symptoms are suspected to be at increased risk of incident inflammatory bowel diseases (
·academic.oup.com·
Association of Depression With Incident Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis | Inflammatory Bowel Diseases | Oxford Academic
A dose‐dependent increase in the risk of inflammatory bowel disease after exposure to broad‐spectrum antibiotics: A national population study in Korea
A dose‐dependent increase in the risk of inflammatory bowel disease after exposure to broad‐spectrum antibiotics: A national population study in Korea
In our large-scale study of 68,633 Koreans with new-onset IBD between 2004 and 2018, we demonstrated dose-dependent relationship between antibiotics use and IBD development.
·onlinelibrary.wiley.com·
A dose‐dependent increase in the risk of inflammatory bowel disease after exposure to broad‐spectrum antibiotics: A national population study in Korea
Effects of gut microbiota on neurodegenerative diseases - PubMed
Effects of gut microbiota on neurodegenerative diseases - PubMed
A progressive degradation of the brain's structure and function, which results in a reduction in cognitive and motor skills, characterizes neurodegenerative diseases (NDs) such as Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). …
·pubmed.ncbi.nlm.nih.gov·
Effects of gut microbiota on neurodegenerative diseases - PubMed
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies - PubMed
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies - PubMed
Human gut microbiota are critical to both the development of and recovery from Clostridioides difficile infection (CDI). Antibiotics are the mainstay of CDI treatment, yet inherently cause further imbalances in the gut microbiota, termed dysbiosis, complicating recovery. A variety of microbio …
·pubmed.ncbi.nlm.nih.gov·
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies - PubMed
Genome Sequence of a Clostridioides difficile Strain Isolated from Feces from a Patient in Southern Thailand - PubMed
Genome Sequence of a Clostridioides difficile Strain Isolated from Feces from a Patient in Southern Thailand - PubMed
Clostridioides difficile is a Gram-positive, obligate anaerobic, toxin-producing bacillus that is linked to antibiotic-associated diarrhea. Here, we report the whole-genome sequence of a C. difficile strain isolated from stool from a patient, using next-generation sequencing (MGISEG-2000). De nov …
·pubmed.ncbi.nlm.nih.gov·
Genome Sequence of a Clostridioides difficile Strain Isolated from Feces from a Patient in Southern Thailand - PubMed
Increasing the Pharmaceutical industry the Clostridium Difficile Infection Drugs Market - Industry Trends and Forecast to 2028
Increasing the Pharmaceutical industry the Clostridium Difficile Infection Drugs Market - Industry Trends and Forecast to 2028
Clostridium Difficile Infection Drugs market report has been prepared by considering several fragments of the present and upcoming market scenario The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape issues that ...
·news.google.com·
Increasing the Pharmaceutical industry the Clostridium Difficile Infection Drugs Market - Industry Trends and Forecast to 2028
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies - PubMed
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies - PubMed
Human gut microbiota are critical to both the development of and recovery from Clostridioides difficile infection (CDI). Antibiotics are the mainstay of CDI treatment, yet inherently cause further imbalances in the gut microbiota, termed dysbiosis, complicating recovery. A variety of microbio …
·pubmed.ncbi.nlm.nih.gov·
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies - PubMed
Characterization of Food Chain Clostridioides difficile Isolates in Terms of Ribotype and Antimicrobial Resistance - PubMed
Characterization of Food Chain Clostridioides difficile Isolates in Terms of Ribotype and Antimicrobial Resistance - PubMed
The aim of this study was to characterize C. difficile isolates from the farm, abattoir, and retail outlets in Ireland in terms of ribotype and antibiotic resistance (vancomycin, erythromycin, metronidazole, moxifloxacin, clindamycin, and rifampicin) using PCR and E-test methods, respectively …
·pubmed.ncbi.nlm.nih.gov·
Characterization of Food Chain Clostridioides difficile Isolates in Terms of Ribotype and Antimicrobial Resistance - PubMed